Aliath Bioventures, the healthcare impact investment platform of AltamarCAM Partners, appoints Philippe Monteyne, MD, PhD as a new Partner to reinforce the company’s healthcare investment team.

As of 16th November 2023, Philippe Monteyne will join the team responsible for Alta Life Sciences Spain I FCR and the newly launched, ACP Aliath Bioventures II FCR (ABV II), specialised in investing in companies in the healthcare sector.

For the past eight years, Philippe has been a Senior Partner of the private equity fund Fund+ in Belgium, having contributed to multiple investments including very profitable ones such as Ogeda and Iteos.

The firm also reinforces the life sciences team with the appointment of Joana Correia as a senior analyst that join Beatriz Gandarias, Jose Maria Fernández and the Alta Life Sciences team

Fuente: AltamarCAM Partners / Aliath Bioventures

https://www.aliathbio.com/appointment-philippe-monteyne/
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

CRB Health Tech realiza el primer cierre...

by CRB Inverbío SA SGECR

Con la incorporación de Sanitas y las suscripciones ya firmadas con a...

Photos Stream